Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC has announced the posting of a Circular and the upcoming General Meeting concerning its recent fundraising activities, following successful Placing, Subscription, and Retail Offer announcements. The biopharmaceutical company, known for enhancing existing therapies to improve patient care, is inviting shareholders to the meeting scheduled for August 8, 2024, in London. Shareholders can access the Circular on the company’s website, signaling continued development in Arecor’s proprietary product portfolio and partnerships.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
